Correlation Between Gilead Sciences and XORTX Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and XORTX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and XORTX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and XORTX Therapeutics, you can compare the effects of market volatilities on Gilead Sciences and XORTX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of XORTX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and XORTX Therapeutics.

Diversification Opportunities for Gilead Sciences and XORTX Therapeutics

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Gilead and XORTX is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and XORTX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XORTX Therapeutics and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with XORTX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XORTX Therapeutics has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and XORTX Therapeutics go up and down completely randomly.

Pair Corralation between Gilead Sciences and XORTX Therapeutics

Given the investment horizon of 90 days Gilead Sciences is expected to generate 0.44 times more return on investment than XORTX Therapeutics. However, Gilead Sciences is 2.27 times less risky than XORTX Therapeutics. It trades about 0.11 of its potential returns per unit of risk. XORTX Therapeutics is currently generating about -0.18 per unit of risk. If you would invest  8,829  in Gilead Sciences on August 31, 2024 and sell it today you would earn a total of  412.00  from holding Gilead Sciences or generate 4.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Gilead Sciences  vs.  XORTX Therapeutics

 Performance 
       Timeline  
Gilead Sciences 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady essential indicators, Gilead Sciences exhibited solid returns over the last few months and may actually be approaching a breakup point.
XORTX Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days XORTX Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Gilead Sciences and XORTX Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gilead Sciences and XORTX Therapeutics

The main advantage of trading using opposite Gilead Sciences and XORTX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, XORTX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XORTX Therapeutics will offset losses from the drop in XORTX Therapeutics' long position.
The idea behind Gilead Sciences and XORTX Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume